Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Alzheon, Inc. v. Risen (Suzhou) Pharma Tech Co., Ltd.
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Alzheon, Inc.
Patent Owner:
Risen (Suzhou) Pharma Tech Co., Ltd.
Tech Center:
1600
-
March 11, 2024
Fed. Circ. OKs Boston Drug Developer's Patent Win
A Boston-area biotech developer that has yet to bring a product to market persuaded the Federal Circuit on Monday to affirm a finding by an administrative patent board last year that stripped a smaller Chinese rival of a patent covering a way of using a type of sulfonic acid to potentially treat Alzheimer's disease.
-
July 13, 2022
Mass. Biotech Biz Gets PTAB To Wipe Alzheimer's Drug Patent
A panel of Patent Trial and Appeal Board judges has sided with arguments from Boston biotech developer Alzheon Inc. that the patent office never should have granted a patent to a smaller Chinese rival that covers a way of using a type of sulfonic acid to potentially treat Alzheimer's disease.
-
April 07, 2022
IP Forecast: Norton Fights Patent Suit, Armed With New Attys
The company behind Norton's AntiVirus brand of malware detection software has armed itself with some new BigLaw guns to defend against a nearly decade-old patent lawsuit that claims some of that software was actually developed by professors at Columbia University. Here's a look at that case — plus all the other major intellectual property matters facing the court in the coming week.
-
July 15, 2021
PTAB Will Review Alzheimer's Treatment Patent
The Patent Trial and Appeal Board has agreed to review a Chinese company's patent involving a treatment for Alzheimer's disease challenged by biotech firm Alzheon Inc.